BDBM387162 2-[(3aR, 7aR)-6-{[2-(2,2- difluorocyclopropyl)phenyl]carbonyl}octa- hydro-1H-pyrrolo[2,3-c]pyridin-1- yl]pyridine-4-carbonitrile::US9938276, E22

SMILES FC1(F)CC1c1ccccc1C(=O)N1CC[C@H]2CCN([C@H]2C1)c1cc(ccn1)C#N

InChI Key InChIKey=RMNZHFJTJSRMTI-LIXNJBPUSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387162   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387162(2-[(3aR, 7aR)-6-{[2-(2,2- difluorocyclopropyl)phen...)
Affinity DataIC50:  1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387162(2-[(3aR, 7aR)-6-{[2-(2,2- difluorocyclopropyl)phen...)
Affinity DataIC50:  43.8nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent